0 results for 'Sanofi SA'
Icahn's Influence Could Dictate ImClone's Decision to Appeal Patent Ruling
Carl Icahn isn't getting his way, at least not yet. ImClone Systems responded to its most famous shareholder's latest attacks by giving him a board seat but keeping Chairman David Kies, despite Icahn's continued public thrashing of him. One indication of Icahn's influence could come in the legal battle over a key patent behind ImClone's sole marketed product, cancer fighter Erbitux. If ImClone reverses course and drops its appeal of the patent case, it would be a concession to one of Icahn's public demands.Vitamin Fight Could Energize Foreign Suits
Vitamin sellers and foreign buyers are playing for multibillion-dollar stakes in a Supreme Court case to be argued April 26. Thomas Goldstein, who will represent the buyers, says the case could answer key questions about the international application of U.S. antitrust law.CVS $25 billion benefit looms with Caremark breakup: real M&A
CVS Caremark Corp., created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.CVS $25 billion benefit looms as SunAmerica agitates for breakup
CVS Caremark Corp. (CVS), created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.Pfizer-Wyeth deal boosts slumping M&As
Pfizer delivered the depressed mergers and acquisitions market some potent medicine as 2009 dawned. In January, the New York-based pharmaceutical giant, looking to replace revenue sapped by increased competition from generic drugs, agreed to buy Wyeth of Madison, N.J., for $68 billion, in the biggest pharma deal since 2004.Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now